Physician profile
Jonathan Robert Murphy
NPI 1013989284
$1,119.49
in general payments reported to CMS, 2019-2025
9 companies · $13.47 in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $267 · 2020: $63.87 · 2021: $175 · 2022: $59.08 · 2023: $220 · 2024: $320 · 2025: $13.47.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $554.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $554.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb Americas INC. | $375.22 | 2022-2025 | Infuse, Xiidra, Miebo |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $369.60 | 2019-2021 | |
| Biotissue Holdings INC. | $125.00 | 2024 | |
| Novartis Pharmaceuticals Corporation | $94.10 | 2019 | |
| Johnson & Johnson Vision Care, INC. | $80.75 | 2019-2023 | Acuvue |
| Coopervision INC. | $32.19 | 2024 | Myday Contact Lens, Clariti Contact Lens |
| Carl Zeiss Meditec Ag | $17.20 | 2020 | |
| Tarsus Pharmaceuticals, INC. | $13.65 | 2024 | Xdemvy |
| Maculogix, INC. | $11.78 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Murphy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.